ARCTIC-BLUE-BEVERAGES
16.9.2022 05:31:40 CEST | Business Wire | Press release
Arctic Blue Legacy Gin is the Company’s latest product to be launched on the market. The product is handcrafted in Finland, matured for 24 months in oak barrels. Arctic Blue Legacy combines Timo Sarpaneva’s world-known glass design with the internationally awarded professionalism of master distiller Asko Ryynänen. Arctic Blue Legacy has been internationally awarded with the highest recognitions at the International Wine and Spirit Competition 2021 and the San Francisco World Spirits Competition 2022.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220915005925/en/
Visualization of Arctic Blue Legacy and its wooden case. (Photo: Business Wire)
The unique design of the Legacy bottle is based on the E415 prototype work designed in 1976 for Iittala by the international force in Finnish design, Timo Sarpaneva (1926-2006). Legacy’s prestige wooden case seeks inspiration from Sarpaneva’s sculpture, Gateway to Dreams. Together with Sarpaneva Design and Infinity, his designs have been subtly adapted to new uses, giving birth to Arctic Blue Legacy’s appearance.
“We are very excited. This fantastic opportunity with an extraordinary product is very inspiring as we are carrying on Timo’s legacy,” says Aleksei Sarpaneva, son of Timo Sarpaneva and CEO of Sarpaneva Design.
Arctic Blue Legacy’s purchase rights will be distributed as NFTs. A non-fungible token is a record on a blockchain associated with a unique, nonreplicable digital or physical asset. Main functionalities of NFTs are proof of digital ownership and holder benefits. The product is stored in Arctic Blue Beverages professional care, until the holder of the NFT decides to exercise their purchase right or transfer the ownership over the Ethereum blockchain. Arctic Blue Legacy is a luxury product, and proof of digital ownership enables a seamless global secondary market facilitating trading or gifting of the NFT.
Arctic Blue Beverages enters the Web3 in collaboration with the Web3 digital agency Struggle C&C Ltd.
“As agency partner, we feel privileged being part of Arctic Blue Beverage’s Web3 transformation. This is a big moment as Arctic Blue Beverages is one of the first listed Nordic companies entering the NFT space. Today’s technology offers new standards for digital ownership and community building”, says Kasper Karimaa, CEO of Struggle C&C.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220915005925/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Samsung Biologics Union Holds First Rally, Warns of May 1 Strike22.4.2026 13:56:00 CEST | Press release
Union estimates about 2,200 participants at one-hour event outside Bio Campus 1 Samsung Biologics’ labor union held its first rally on Tuesday and said it would move ahead with a strike on May 1 if management continues to reject meaningful talks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422754766/en/ Union members gather at a rally organized by the Samsung Biologics labor union outside Bio Campus 1 in Songdo, Incheon, on April 22, ahead of a planned May 1 strike. The rally, held for about an hour outside the main gate of the company’s Bio Campus 1 in Songdo, drew about 2,200 participants, according to the union. The event marks an escalation in a labor dispute that union leaders say is no longer limited to a small number of bargaining items, but instead concerns broader questions about accountability and decision-making within the company. Park Jaesung, chair of the Samsung Biologics union, said management had faile
HCL Group and UpLink Launch Fifth Global Aquapreneur Innovation Challenge to Advance Future Water Systems22.4.2026 13:16:00 CEST | Press release
HCL Group, in partnership with UpLink - the early-stage innovation initiative of the World Economic Forum - has launched the fifth global challenge under the Aquapreneur Innovation Initiative, titled Transforming Water Systems. Applications will be open from 22 April to 4 June 2026. The top 10 winners will receive a total financial award of CHF 1.75 million. For details on eligibility and application criteria, visit: UpLink - Transforming Water Systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260421866128/en/ The Aquapreneur Innovation Initiative is a five-year, CHF 15 million collaboration between UpLink, HCL Group, and the World Economic Forum’s Food and Water Initiative, focused on building a global innovation ecosystem for freshwater solutions. Important Dates to Note 22 April to 4 June 2026 Open for submissions July to August 2026 Review and selection process January 2027 Announcement of the winners As water syst
Veristat to Acquire Certara’s Regulatory and Medical Writing Business22.4.2026 13:00:00 CEST | Press release
Strategic acquisition expands and enhances Veristat’s regulatory services to help more clinical trial sponsors develop novel, life-saving therapies across complex disease areas Veristat (the “Company”), a science-first full-service CRO and consultancy that advances complex therapies through the drug development lifecycle to regulatory submission, announced today its intended acquisition of Certara’s Regulatory and Medical Writing business. The team that will join Veristat is known for its white-glove advisory services and deep expertise authoring clinical and non-clinical documents throughout the drug development lifecycle. The acquisition is supported by WindRose Health Investors, LLC, a New York-based healthcare private equity firm, which remains a partner in driving Veristat's growth trajectory and mission. Notably, the acquisition expands Veristat’s regulatory writing and submission capabilities by adding more than 200 industry experts. Combined with the strong track record and mar
BeOne Medicines to Announce First Quarter 2026 Financial Results on May 622.4.2026 12:01:00 CEST | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its first quarter 2026 financial results on Wednesday, May 6, 2026 before the financial markets open. Following the release of the financials, the Company will host a live webcast with management at 8:00 a.m. ET. The live webcast of this event can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com.To ensure a timely connection, it is recommended that participants register at least 15 minutes prior to the scheduled webcast. An archived webcast will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capa
Smartstream Research Reveals Five Realities Redefining Buy-Side Reconciliations22.4.2026 10:05:00 CEST | Press release
Key Facts Over 70% of firms still rely primarily on end-of-day reconciliation, while 53% cite timing differences and data mismatches as the leading causes of breaks. 59% of participants identified external data dependencies as the primary risk, while 47% highlighted internal inconsistencies. And 41% struggle with incomplete or insufficiently enriched data. 69% describe their T+1 model as partially adapted and still evolving. Whilst 41% say T+1 has made data quality a critical priority. Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces new findings from its latest industry research report, Smart Reconciliations: The Buy-Side Perspective, highlighting the structural shifts transforming reconciliation, control, and operational confidence across buy-side firms. Based on insights gathered from a roundtable of senior operations leaders across asset management and investment firms, the report identifies five critical re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom